- Home
- MKZR vs XAIR Comparison
MKZR vs XAIR Comparison
Compare MKZR & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MKZR | XAIR |
|---|---|---|
| Founded | 2012 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7M | 3.0M |
| IPO Year | 2012 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MKZR | XAIR |
|---|---|---|
| Price | $1.14 | $2.09 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 8.8K | ★ 57.1K |
| Earning Date | 11-13-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.87 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $20,007,414.00 | $7,679,000.00 |
| Revenue This Year | N/A | $4.23 |
| Revenue Next Year | N/A | $108.84 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 107.26 |
| 52 Week Low | $0.83 | $0.33 |
| 52 Week High | $5.60 | $8.19 |
Technical Indicators
Market Signals| Indicator | MKZR | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 34.75 | 36.57 |
| Support Level | $0.83 | $2.05 |
| Resistance Level | $1.55 | $3.30 |
| Average True Range (ATR) | 0.09 | 0.19 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 24.08 | 19.48 |
Price Performance
Historical ComparisonAbout MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a real estate investment manager and a real estate investment trust (REIT) engaged in discounted real estate securities and asset management. The Company operates through two primary operating and reportable segments: commercial, which generates maximum revenue, and residential. These segments include activities related to acquiring, owning, developing, and managing income-producing real estate properties. Its properties are geographically diversified throughout the United States.
About XAIR Beyond Air Inc.
Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.